Literature DB >> 12673266

Umbilical cord blood serum procalcitonin concentration in the diagnosis of early neonatal infection.

Agnieszka Kordek1, Stefania Giedrys-Kalemba, Beata Pawlus, Wojciech Podraza, Ryszard Czajka.   

Abstract

OBJECTIVE: To evaluate serum procalcitonin concentration in umbilical cord blood for diagnosis of intrauterine bacterial infection.
MATERIALS AND METHODS: A prospective study was conducted between 2000 and 2001. Serum procalcitonin concentrations were evaluated in 187 umbilical cord blood samples. Five groups have been defined: controls A (n=37), full-term noninfected B1 (n=80) and infected neonates B2 (n=8), preterm noninfected C1 (n=38) and infected C2 (n=24) newborns. An immunoluminometric assay was used to determine procalcitonin concentration. The Mann-Whitney U-test and Spearman's correlation ratio were applied. The sensitivity and specificity, the positive and negative predictive values, and the area under receiver operating characteristic curves were calculated.
RESULTS: A statistically higher serum procalcitonin concentration was found in the preterm infected group (p<0.005; C2 vs A and C1).
CONCLUSION: Serum procalcitonin concentration in umbilical cord blood may be a useful parameter in the diagnosis of early neonatal infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12673266     DOI: 10.1038/sj.jp.7210885

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  7 in total

Review 1.  Inflammatory markers in cord blood or maternal serum for early detection of neonatal sepsis-a systemic review and meta-analysis.

Authors:  H Su; S-S Chang; C-M Han; K-Y Wu; M-C Li; C-Y Huang; C-L Lee; J-Y Wu; C-C Lee
Journal:  J Perinatol       Date:  2014-01-23       Impact factor: 2.521

Review 2.  Regenerative Therapy Using Umbilical Cord Serum.

Authors:  Nagarajan Maharajan; Gwang-Won Cho; Ji Hyun Choi; Chul Ho Jang
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

3.  Cerebrospinal fluid procalcitonin as a biomarker of bacterial meningitis in neonates.

Authors:  Z Reshi; M Nazir; W Wani; M Malik; J Iqbal; S Wajid
Journal:  J Perinatol       Date:  2017-05-25       Impact factor: 2.521

4.  Clinical chorioamnionitis at term VI: acute chorioamnionitis and funisitis according to the presence or absence of microorganisms and inflammation in the amniotic cavity.

Authors:  Roberto Romero; Piya Chaemsaithong; Nikolina Docheva; Steven J Korzeniewski; Juan P Kusanovic; Bo Hyun Yoon; Jung-Sun Kim; Noppadol Chaiyasit; Ahmed I Ahmed; Faisal Qureshi; Suzanne M Jacques; Chong Jai Kim; Sonia S Hassan; Tinnakorn Chaiworapongsa; Lami Yeo; Yeon Mee Kim
Journal:  J Perinat Med       Date:  2016-01       Impact factor: 1.901

Review 5.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

6.  Neonatal Procalcitonin Intervention Study (NeoPInS): Effect of Procalcitonin-guided decision making on duration of antibiotic therapy in suspected neonatal early-onset sepsis: A multi-centre randomized superiority and non-inferiority Intervention Study.

Authors:  Martin Stocker; Wim C J Hop; Annemarie M C van Rossum
Journal:  BMC Pediatr       Date:  2010-12-08       Impact factor: 2.125

Review 7.  Is Procalcitonin Useful in Pediatric Critical Care Patients?

Authors:  Sara Bobillo-Perez; Javier Rodríguez-Fanjul; Iolanda Jordan Garcia
Journal:  Biomark Insights       Date:  2018-08-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.